Bob
Have a question related to this hub?
Alice
Got something to say related to this hub?
Share it here.
| Clinical data | |
|---|---|
| Other names | Triptax™ |
| Drug class | Undefined[1][2] |
Triptax is a drug which is under development for the treatment of depressive disorders and treatment-resistant depression.[1][2][3][4] Its mechanism of action has not been defined.[1][2] The drug is being developed by Biomind Labs.[1][2] As of December 2022, it is in the preclinical research stage of development.[1][2] The chemical structure of Triptax does not yet seem to have been disclosed, but it is described as a new chemical entity.[1][4] Aside from Triptax, Biomind Labs is also developing a variety of defined serotonergic agents and serotonergic psychedelics for treatment of various conditions.[5]
 | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
